Haixin Wang

Title: Haixin Wang: Innovator in Pharmaceutical Synthesis

Introduction

Haixin Wang is a notable inventor based in Linyi, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of important drug intermediates. His work is characterized by innovative methods that enhance the efficiency of chemical processes.

Latest Patents

Wang holds a patent for a synthetic method for montelukast sodium intermediate. This patent describes a synthesis method for preparing the Montelukast sodium intermediate 2-(2-(3-(2-(7-chloro-2-quinolyl)vinyl)phenyl-3-oxopropyl)phenyl)propanol. The method involves condensing the starting materials 7-chloroquinaldine and 3-cyanobenzaldehyde, followed by a reaction with 2-(2-ortho-(2-haloethyl)-phenylpropyl)tetrahydropyrane ether. This innovative approach allows for the easy acquisition of starting materials and is suitable for mass production.

Career Highlights

Wang is associated with Shandong New Time Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical synthesis. His work has contributed to advancements in the production of essential medications, showcasing his commitment to improving healthcare through innovation.

Collaborations

Wang has collaborated with notable colleagues, including Zhiquan Zhao and Zengxue Wang. These partnerships have fostered a collaborative environment that enhances research and development efforts within the pharmaceutical industry.

Conclusion

Haixin Wang's contributions to pharmaceutical synthesis exemplify the impact of innovative thinking in drug development. His patent for the synthesis of montelukast sodium intermediate highlights his role as a key player in advancing pharmaceutical chemistry. Wang's work continues to influence the industry, paving the way for more efficient drug production methods.